Compare Katakura Industries Co., Ltd. with Similar Stocks
Dashboard
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 29.19
2
Poor long term growth as Net Sales has grown by an annual rate of 0.51% over the last 5 years
3
Positive results in Mar 26
4
With ROE of 5.96%, it has a fair valuation with a 1.06 Price to Book Value
5
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
JPY 86,594 Million (Small Cap)
18.00
NA
0.02%
-0.22
6.21%
0.86
Revenue and Profits:
Net Sales:
11,157 Million
(Quarterly Results - Mar 2026)
Net Profit:
1,778 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.71%
0%
-18.71%
6 Months
-21.8%
0%
-21.8%
1 Year
3.79%
0%
3.79%
2 Years
9.0%
0%
9.0%
3 Years
45.43%
0%
45.43%
4 Years
21.37%
0%
21.37%
5 Years
59.53%
0%
59.53%
Katakura Industries Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.51%
EBIT Growth (5y)
9.49%
EBIT to Interest (avg)
29.19
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.42
Tax Ratio
49.16%
Dividend Payout Ratio
33.20%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.23%
ROE (avg)
5.85%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
1.06
EV to EBIT
14.13
EV to EBITDA
9.34
EV to Capital Employed
1.08
EV to Sales
1.97
PEG Ratio
0.41
Dividend Yield
0.02%
ROCE (Latest)
7.67%
ROE (Latest)
5.96%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
11,157.00
10,507.00
6.19%
Operating Profit (PBDIT) excl Other Income
2,761.00
1,923.00
43.58%
Interest
31.00
32.00
-3.13%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,778.00
901.00
97.34%
Operating Profit Margin (Excl OI)
182.90%
100.00%
8.29%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 6.19% vs 11.90% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 97.34% vs -32.71% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
40,652.00
39,424.00
3.11%
Operating Profit (PBDIT) excl Other Income
8,757.00
6,947.00
26.05%
Interest
131.00
141.00
-7.09%
Exceptional Items
0.00
-902.00
100.00%
Consolidate Net Profit
5,815.00
3,744.00
55.32%
Operating Profit Margin (Excl OI)
144.10%
104.60%
3.95%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 3.11% vs -1.37% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 55.32% vs 15.88% in Dec 2024
About Katakura Industries Co., Ltd. 
Katakura Industries Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






